Capula Management LTD Abb Vie Inc. Put Options Transaction History

Capula Management LTD

$9.23 Billion
Q3 2024

Put Options

21 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 13, 2024	SELL	$163.84 - $199.33 $475,136 - $578,057	-2,900 Reduced 54.72%	2,400 $473,000
Q2 2024 Aug 05, 2024	BUY	$154.79 - $180.76 $773,950 - $903,800	5,000 Added 1666.67%	5,300 $909,000
Q1 2024 May 09, 2024	BUY	$159.82 - $182.1 $47,946 - $54,630	300 New	300 $54,000
Q3 2023 Nov 03, 2023	SELL	$133.59 - $154.65 $4.88 Million - $5.64 Million	-36,500 Reduced 85.48%	6,200 $924,000
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $19.4 Million - $24.1 Million	-146,100 Reduced 77.38%	42,700 $5.75 Million
Q1 2023 May 10, 2023	BUY	$144.61 - $166.54 $15.4 Million - $17.7 Million	106,500 Added 129.4%	188,800 $30.1 Million
Q4 2022 Feb 14, 2023	SELL	$138.31 - $165.87 $8.71 Million - $10.4 Million	-63,000 Reduced 43.36%	82,300 $13.3 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $7.35 Million - $8.44 Million	54,800 Added 60.55%	145,300 $19.5 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $5.3 Million - $6.74 Million	38,500 Added 74.04%	90,500 $13.9 Million
Q1 2022 May 17, 2022	BUY	$131.98 - $163.75 $6.86 Million - $8.52 Million	52,000 New	52,000 $8.43 Million
Q4 2021 Feb 14, 2022	SELL	$107.43 - $135.93 $14 Million - $17.7 Million	-130,400 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $9.58 Million - $10.9 Million	90,000 Added 222.77%	130,400 $13.9 Million
Q2 2021 Aug 13, 2021	SELL	$105.21 - $117.21 $5.63 Million - $6.27 Million	-53,500 Reduced 56.98%	40,400 $4.5 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $5.26 Million - $5.79 Million	51,400 Added 120.94%	93,900 $10.2 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $3.42 Million - $4.62 Million	42,500 New	42,500 $4.55 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $9.41 Million - $11 Million	-109,500 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $3.49 Million - $4.67 Million	-47,600 Reduced 30.3%	109,500 $10.8 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $7.6 Million - $11.5 Million	-117,900 Reduced 42.87%	157,100 $12 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $14.4 Million - $18.1 Million	200,000 Added 266.67%	275,000 $24.3 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $3.62 Million - $4.35 Million	57,500 Added 328.57%	75,000 $5.68 Million
Q2 2019 Aug 09, 2019	BUY	$65.7 - $83.98 $1.15 Million - $1.47 Million	17,500 New	17,500 $1.27 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capula Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Capula Management LTD with notifications on news.

Account